Future students

Course search

print
 

Unit details

Return to previous page

HMM304 - Therapeutic Development

Enrolment modes:Trimester 2: Burwood (Melbourne), Waurn Ponds (Geelong)
Credit point(s):1
EFTSL value:0.125
Unit chair:

A Mellick

Prerequisite:

HMM301

Contact hours:

3 x 1 hour classes per week, and cloud (online) exercises, case studies, debates and discussions

Note:

You will need to access substantial learning resources and experiences in CloudDeakin (Deakin’s online learning environment). Compliance with the Standards in computing, connectivity and student capability are a condition on your enrolment.

Content

This unit describes how therapeutic targets are identified and how new therapies are developed for human use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents, and covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing.

Assessment

Mid-semester test (45 minutes) 20%, written report (1200 words) 25%, case study (1200 words) 25%, examination (2 hours) 30%

Prescribed texts

Rang HP. 2006. Drug Discovery and Development: Technology in Transition. 1st Ed. Churchill Livingstone, Edinburgh, UK

Unit Fee Information

Student Contribution Rate*Student Contribution Rate**Fee rate - Domestic Students Fee rate - International students
$1076$1076$3750$3503

* Rate for all CSP students, except for those who commenced Education and Nursing units pre 2010
** Rate for CSP students who commenced Education and Nursing units pre 2010
Please note: Unit fees listed do not apply to Deakin Prime students.

Return to previous page

Deakin University acknowledges the traditional land owners of present campus sites.

8th June 2007